ADDED
(Exact name of registrant as specified in its charter) Florida 85-3354547 (State or other jurisdiction of (I.R.S.
See definition of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
As of March 12, 2026, there were 34,380,971 shares of common stock issued and outstanding.
Executive Compensation 59 Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 59 Item 13.
Risks Relating to Our Proposed Merger with TELI Pharmaceuticals, Inc.
( TELI ) Because TELI has a limited operating history, you may not be able to accurately evaluate TELI s operations.
TELI has significant and increasing liquidity needs and will require additional funding.
TELI has yet to generate revenues or achieve a profit and may not generate revenue or achieve a profit for many years, if at all.
TELI does not own rights to Telomir-1 TELI s product candidates, if approved, may not achieve the expected market acceptance and, consequently, limit TELI s ability to generate revenue.
There are several conflicts of interests inherent in the Merger.
REMOVED
(Exact name of registrant as specified in its charter) Florida 87-2606031 (State or other jurisdiction of incorporation or organization) (I.R.S.
See definition of large accelerated filer , accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Executive Compensation 61 Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 70 Item 13.
Description of Business Overview Telomir-1 is a novel oral small molecule metal ion regulator designed to extend telomere caps, maintain cellular balance, and combat oxidative stress, a key driver of aging and disease progression.
By modulating essential metal ions such as iron, and copper, Telomir-1 may help protect against age-related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson s disease (a genetic disorder leading to toxic copper buildup in the body), and Age-related Macular Degeneration (AMD), as well as Type 2 Diabetes, cancer, and Alzheimer s disease.
Oxidative stress also plays a critical role in the propagation and severity of viral infections like bird flu, where the virus triggers an imbalance between increased production of reactive oxygen species (ROS) and reduced antioxidant host responses that leads to increased redox stress, a process which ultimately excessive weakens immune defenses, increases inflammation, and enables enhanced viral replication.
By reversing oxidative stress, Telomir-1 may help strengthen immune resilience and reduce disease severity, offering broad therapeutic potential across both age-related and infectious diseases.
Telomeres are repetitive DNA sequences at the end of chromosomes that protect the chromosomes from becoming frayed or tangled.
Each time a cell divides, the telomeres become slightly shorter, and eventually they become so short that the cell can no longer divide, with the result being that the cell dies.
Effectively, telomeres protect the ends of our chromosomes by forming a cap, much like the plastic tip on shoelaces, thereby allowing the chromosome to be replaced properly during cell division.